U.S.: FDA Approves First CRISPR Treatment for Sickle Cell Disease

The U.S. Food and Drug Administration approved the world's first CRISPR treatment, which leverages gene-editing technology, for individuals suffering from sickle cell disease, The Wall Street Journal reported on Dec. 8....